|  | | VQS |  | Name: | N-(4-{4-[1-(cyclopropylsulfonyl)cyclopropyl]-6-[(3S)-3-methylmorpholin-4-yl]pyrimidin-2-yl}phenyl)-N'-(2-hydroxyethyl)thiourea |  | Formula: | C24 H31 N5 O4 S2 |  | SMILES: | C1C(C1)S(C5(c3cc(nc(c2ccc(cc2)NC(=S)NCCO)n3)N4C(C)COCC4)CC5)(=O)=O |  | InChi: | InChI=1S/C24H31N5O4S2/c1-16-15-33-13-11-29(16)21-14-20(24(8-9-24)35(31,32)19-6-7-19)27-22(28-21)17-2-4-18(5-3-17)26-23(34)25-10-12-30/h2-5,14,16,19,30H,6-13,15H2,1H3,(H2,25,26,34)/t16-/m0/s1 |  | Definition date: | 2020-09-08 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | N-(4-{4-[1-(cyclopropylsulfonyl)cyclopropyl]-6-[(3S)-3-methylmorpholin-4-yl]pyrimidin-2-yl}phenyl)-N'-(2-hydroxyethyl)thiourea | 
 | 
|  | | UJH |  | Name: | 1-methoxy-4-oxoquinoline |  | Formula: | C10 H9 N O2 |  | SMILES: | CON1C=CC(=O)c2ccccc12 |  | InChi: | InChI=1S/C10H9NO2/c1-13-11-7-6-10(12)8-4-2-3-5-9(8)11/h2-7H,1H3 |  | Synonyms: | 1-methoxyquinolin-4-one |  | Definition date: | 2021-02-23 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | 1-methoxyquinolin-4-one | 
 | 
|  | | UK5 |  | Name: | 1-oxidanylquinolin-4-one |  | Formula: | C9 H7 N O2 |  | SMILES: | ON1C=CC(=O)c2ccccc12 |  | InChi: | InChI=1S/C9H7NO2/c11-9-5-6-10(12)8-4-2-1-3-7(8)9/h1-6,12H |  | Definition date: | 2021-02-26 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | 1-oxidanylquinolin-4-one | 
 | 
|  | | XJ7 |  | Name: | (2S)-1-(butanoyloxy)-3-{[(R)-hydroxy{[(1r,2R,3S,4S,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propan-2-yl tridecanoate |  | Formula: | C26 H49 O13 P |  | SMILES: | CCCC(=O)OCC(COP(OC1C(C(C(C(O)C1O)O)O)O)(O)=O)OC(CCCCCCCCCCCC)=O |  | InChi: | InChI=1S/C26H49O13P/c1-3-5-6-7-8-9-10-11-12-13-15-20(28)38-18(16-36-19(27)14-4-2)17-37-40(34,35)39-26-24(32)22(30)21(29)23(31)25(26)33/h18,21-26,29-33H,3-17H2,1-2H3,(H,34,35)/t18-,21-,22+,23-,24-,25+,26+/m0/s1 |  | Definition date: | 2020-12-17 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | (2S)-1-(butanoyloxy)-3-{[(R)-hydroxy{[(1r,2R,3S,4S,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propan-2-yl tridecanoate | 
 | 
|  | | XJA |  | Name: | (2S)-1-(butanoyloxy)-3-{[(R)-hydroxy{[(1S,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propan-2-yl tridecanoate |  | Formula: | C26 H49 O13 P |  | SMILES: | CCCC(OCC(COP(OC1C(C(C(O)C(C1O)O)O)O)(O)=O)OC(=O)CCCCCCCCCCCC)=O |  | InChi: | InChI=1S/C26H49O13P/c1-3-5-6-7-8-9-10-11-12-13-15-20(28)38-18(16-36-19(27)14-4-2)17-37-40(34,35)39-26-24(32)22(30)21(29)23(31)25(26)33/h18,21-26,29-33H,3-17H2,1-2H3,(H,34,35)/t18-,21-,22+,23+,24+,25-,26+/m0/s1 |  | Definition date: | 2020-12-17 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | (2S)-1-(butanoyloxy)-3-{[(R)-hydroxy{[(1S,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propan-2-yl tridecanoate | 
 | 
|  | | XJD |  | Name: | (10R,13S)-16-amino-13-hydroxy-7,13-dioxo-8,12,14-trioxa-13lambda~5~-phosphahexadecan-10-yl tridecanoate |  | Formula: | C25 H50 N O8 P |  | SMILES: | C(OP(OCC(COC(=O)CCCCCC)OC(CCCCCCCCCCCC)=O)(=O)O)CN |  | InChi: | InChI=1S/C25H50NO8P/c1-3-5-7-9-10-11-12-13-14-16-18-25(28)34-23(22-33-35(29,30)32-20-19-26)21-31-24(27)17-15-8-6-4-2/h23H,3-22,26H2,1-2H3,(H,29,30)/t23-/m1/s1 |  | Definition date: | 2020-12-17 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | (10R,13S)-16-amino-13-hydroxy-7,13-dioxo-8,12,14-trioxa-13lambda~5~-phosphahexadecan-10-yl tridecanoate | 
 | 
|  | | XKP |  | Name: | (11R,14S)-17-amino-14-hydroxy-8,14-dioxo-9,13,15-trioxa-14lambda~5~-phosphaheptadecan-11-yl decanoate |  | Formula: | C23 H46 N O8 P |  | SMILES: | C(CCCCCCCCC)(=O)OC(COC(=O)CCCCCCC)COP(O)(=O)OCCN |  | InChi: | InChI=1S/C23H46NO8P/c1-3-5-7-9-10-12-14-16-23(26)32-21(20-31-33(27,28)30-18-17-24)19-29-22(25)15-13-11-8-6-4-2/h21H,3-20,24H2,1-2H3,(H,27,28)/t21-/m1/s1 |  | Definition date: | 2020-12-18 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | (11R,14S)-17-amino-14-hydroxy-8,14-dioxo-9,13,15-trioxa-14lambda~5~-phosphaheptadecan-11-yl decanoate | 
 | 
|  | | X7Y |  | Name: | 2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}-5,11-dimethyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one |  | Formula: | C25 H29 N7 O2 |  | SMILES: | n3c(Nc2c(cc(N1CCN(C)CC1)cc2)OC)ncc4c3N(C)c5c(C(N4C)=O)cccc5 |  | InChi: | InChI=1S/C25H29N7O2/c1-29-11-13-32(14-12-29)17-9-10-19(22(15-17)34-4)27-25-26-16-21-23(28-25)30(2)20-8-6-5-7-18(20)24(33)31(21)3/h5-10,15-16H,11-14H2,1-4H3,(H,26,27,28) |  | Definition date: | 2020-12-03 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | 2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}-5,11-dimethyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one | 
 | 
|  | | X8J |  | Name: | 5-ethyl-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}-11-methyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one |  | Formula: | C26 H31 N7 O2 |  | SMILES: | n3c(Nc2c(cc(N1CCN(C)CC1)cc2)OC)ncc4c3N(C)c5c(C(N4CC)=O)cccc5 |  | InChi: | InChI=1S/C26H31N7O2/c1-5-33-22-17-27-26(29-24(22)31(3)21-9-7-6-8-19(21)25(33)34)28-20-11-10-18(16-23(20)35-4)32-14-12-30(2)13-15-32/h6-11,16-17H,5,12-15H2,1-4H3,(H,27,28,29) |  | Definition date: | 2020-12-03 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | 5-ethyl-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}-11-methyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one | 
 | 
|  | | SBV |  | Name: | (1R,2S,3S,4R,6S)-4,6-diamino-3-{[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl]oxy}-2-hydroxycyclohexyl 2-amino-2,3,4,6-tetradeoxy-6-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]-beta-L-threo-hexopyranoside |  | Formula: | C27 H49 N6 O12 P |  | SMILES: | c4(CNCC3CCC(C(OC1C(CC(N)C(C1O)OC2C(O)C(NC)C(CO2)(C)O)N)O3)N)c(COP(O)(O)=O)cnc(c4O)C |  | InChi: | InChI=1S/C27H49N6O12P/c1-12-19(34)15(13(7-33-12)10-42-46(38,39)40)9-32-8-14-4-5-16(28)25(43-14)44-22-17(29)6-18(30)23(20(22)35)45-26-21(36)24(31-3)27(2,37)11-41-26/h7,14,16-18,20-26,31-32,34-37H,4-6,8-11,28-30H2,1-3H3,(H2,38,39,40)/t14-,16-,17+,18-,20+,21-,22-,23+,24-,25-,26-,27+/m1/s1 |  | Synonyms: | PLP-sisomicin |  | Definition date: | 2020-03-06 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | (1R,2S,3S,4R,6S)-4,6-diamino-3-{[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl]oxy}-2-hydroxycyclohexyl 2-amino-2,3,4,6-tetradeoxy-6-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]-beta-L-threo-hexopyranoside | 
 | 
|  | | U8N |  | Name: | 4-oxidanyl-2~{H}-isoquinolin-1-one |  | Formula: | C9 H7 N O2 |  | SMILES: | OC1=CNC(=O)c2ccccc12 |  | InChi: | InChI=1S/C9H7NO2/c11-8-5-10-9(12)7-4-2-1-3-6(7)8/h1-5,11H,(H,10,12) |  | Definition date: | 2021-02-02 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | 4-oxidanyl-2~{H}-isoquinolin-1-one | 
 | 
|  | | TG2 |  | Name: | 4-(4-phenylphenyl)carbonyloxypyrrolidine-2-carboxylic acid |  | Formula: | C18 H17 N O4 |  | SMILES: | OC(=O)[CH]1C[CH](CN1)OC(=O)c2ccc(cc2)c3ccccc3 |  | InChi: | InChI=1S/C18H17NO4/c20-17(21)16-10-15(11-19-16)23-18(22)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-9,15-16,19H,10-11H2,(H,20,21)/t15-,16-/m1/s1 |  | Definition date: | 2020-12-22 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | 4-(4-phenylphenyl)carbonyloxypyrrolidine-2-carboxylic acid | 
 | 
|  | | TJ5 |  | Name: | (2~{S},4~{S})-4-(4-phenylphenyl)carbonyloxypyrrolidine-2-carboxylic acid |  | Formula: | C18 H17 N O4 |  | SMILES: | OC(=O)[CH]1C[CH](CN1)OC(=O)c2ccc(cc2)c3ccccc3 |  | InChi: | InChI=1S/C18H17NO4/c20-17(21)16-10-15(11-19-16)23-18(22)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-9,15-16,19H,10-11H2,(H,20,21)/t15-,16-/m0/s1 |  | Definition date: | 2020-12-22 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | (2~{S},4~{S})-4-(4-phenylphenyl)carbonyloxypyrrolidine-2-carboxylic acid | 
 | 
|  | | 7T8 |  | Name: | (3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[(acetyloxy)methyl]-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl diacetate |  | Formula: | C31 H37 N O10 |  | SMILES: | CC(=O)OC1CCC2(C)C(CC(OC(C)=O)C3(C)OC=4C=C(OC(=O)C=4C(O)C32)c2cccnc2)C1(C)COC(C)=O |  | InChi: | InChI=1S/C31H37NO10/c1-16(33)38-15-30(5)22-13-24(40-18(3)35)31(6)27(29(22,4)10-9-23(30)39-17(2)34)26(36)25-21(42-31)12-20(41-28(25)37)19-8-7-11-32-14-19/h7-8,11-12,14,22-24,26-27,36H,9-10,13,15H2,1-6H3/t22-,23+,24+,26+,27-,29+,30+,31-/m1/s1 |  | Definition date: | 2021-08-19 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | (3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[(acetyloxy)methyl]-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl diacetate | 
 | 
|  | | 73I |  | Name: | (1S,2R,4S,5S,6S)-N,5,6-tris(4-hydroxyphenyl)-N-(2,2,2-trifluoroethyl)-7-oxabicyclo[2.2.1]heptane-2-sulfonamide |  | Formula: | C26 H22 F3 N O6 S |  | SMILES: | O=S(=O)(C1CC2OC1C(=C2c1ccc(O)cc1)c1ccc(O)cc1)N(CC(F)(F)F)c1ccc(O)cc1 |  | InChi: | InChI=1S/C26H22F3NO6S/c27-26(28,29)14-30(17-5-11-20(33)12-6-17)37(34,35)22-13-21-23(15-1-7-18(31)8-2-15)24(25(22)36-21)16-3-9-19(32)10-4-16/h1-12,21-22,25,31-33H,13-14H2/t21-,22+,25+/m0/s1 |  | Definition date: | 2021-08-11 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | (1S,2R,4S)-N,5,6-tris(4-hydroxyphenyl)-N-(2,2,2-trifluoroethyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonamide | 
 | 
|  | | 7AI |  | Name: | (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-N-{4-[2-(piperidin-1-yl)ethoxy]phenyl}-N-(2,2,2-trifluoroethyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonamide |  | Formula: | C33 H35 F3 N2 O6 S |  | SMILES: | O=S(=O)(C1CC2OC1C(=C2c1ccc(O)cc1)c1ccc(O)cc1)N(CC(F)(F)F)c1ccc(OCCN2CCCCC2)cc1 |  | InChi: | InChI=1S/C33H35F3N2O6S/c34-33(35,36)21-38(24-8-14-27(15-9-24)43-19-18-37-16-2-1-3-17-37)45(41,42)29-20-28-30(22-4-10-25(39)11-5-22)31(32(29)44-28)23-6-12-26(40)13-7-23/h4-15,28-29,32,39-40H,1-3,16-21H2/t28-,29+,32+/m0/s1 |  | Definition date: | 2021-08-11 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-N-{4-[2-(piperidin-1-yl)ethoxy]phenyl}-N-(2,2,2-trifluoroethyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonamide | 
 | 
|  | | 3VI |  | Name: | 1,1'-methylenebis{4-[(E)-(hydroxyimino)methyl]pyridin-1-ium} |  | Formula: | C13 H14 N4 O2 |  | SMILES: | ON=Cc1cc[n+](C[n+]2ccc(C=NO)cc2)cc1 |  | InChi: | InChI=1S/C13H12N4O2/c18-14-9-12-1-5-16(6-2-12)11-17-7-3-13(4-8-17)10-15-19/h1-10H,11H2/p+2 |  | Definition date: | 2021-07-06 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | 1,1'-methylenebis{4-[(E)-(hydroxyimino)methyl]pyridin-1-ium} | 
 | 
|  | | 7EI |  | Name: | (1R,2S,4R)-5-(4-hydroxyphenyl)-N-(4-methoxyphenyl)-6-{4-[2-(piperidin-1-yl)ethoxy]phenyl}-N-(2,2,2-trifluoroethyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonamide |  | Formula: | C34 H37 F3 N2 O6 S |  | SMILES: | O=S(=O)(C1CC2OC1C(=C2c1ccc(O)cc1)c1ccc(OCCN2CCCCC2)cc1)N(CC(F)(F)F)c1ccc(OC)cc1 |  | InChi: | InChI=1S/C34H37F3N2O6S/c1-43-27-15-9-25(10-16-27)39(22-34(35,36)37)46(41,42)30-21-29-31(23-5-11-26(40)12-6-23)32(33(30)45-29)24-7-13-28(14-8-24)44-20-19-38-17-3-2-4-18-38/h5-16,29-30,33,40H,2-4,17-22H2,1H3/t29-,30+,33+/m1/s1 |  | Definition date: | 2021-08-11 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | (1R,2S,4R)-5-(4-hydroxyphenyl)-N-(4-methoxyphenyl)-6-{4-[2-(piperidin-1-yl)ethoxy]phenyl}-N-(2,2,2-trifluoroethyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonamide | 
 | 
|  | | 7Q9 |  | Name: | [(2~{R})-3-[oxidanyl-[2-(trimethyl-$l^{4}-azanyl)ethoxy]phosphoryl]oxy-2-propanoyloxy-propyl] (~{Z})-octadec-9-enoate |  | Formula: | C29 H57 N O8 P |  | SMILES: | C[N+](C)(C)CCOP(O)(=O)OCC(COC(=O)CCCCCCC/C=CCCCCCCCC)OC(=O)CC |  | InChi: | InChI=1S/C29H56NO8P/c1-6-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-29(32)35-25-27(38-28(31)7-2)26-37-39(33,34)36-24-23-30(3,4)5/h14-15,27H,6-13,16-26H2,1-5H3/p+1/b15-14-/t27-/m1/s1 |  | Definition date: | 2021-08-17 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | (4S,7R,18Z)-4-hydroxy-N,N,N-trimethyl-4,10-dioxo-7-(propanoyloxy)-3,5,9-trioxa-4lambda~5~-phosphaheptacos-18-en-1-aminium | 
 | 
|  | | 87N |  | Name: | [(2~{R},3~{R},4~{S},5~{S},6~{R})-4-acetamido-6-methyl-3,5-bis(oxidanyl)oxan-2-yl] [[(2~{R},3~{S},5~{R})-5-[5-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] hydrogen phosphate |  | Formula: | C18 H29 N3 O15 P2 |  | SMILES: | CC1=CN(C(=O)NC1=O)C1CC(O)C(O1)COP(=O)(O)OP(=O)(O)OC1OC(C)C(O)C(NC(C)=O)C1O |  | InChi: | InChI=1S/C18H29N3O15P2/c1-7-5-21(18(27)20-16(7)26)12-4-10(23)11(34-12)6-32-37(28,29)36-38(30,31)35-17-15(25)13(19-9(3)22)14(24)8(2)33-17/h5,8,10-15,17,23-25H,4,6H2,1-3H3,(H,19,22)(H,28,29)(H,30,31)(H,20,26,27)/t8-,10+,11-,12-,13+,14-,15-,17-/m1/s1 |  | Definition date: | 2021-09-09 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | (2R,3R,4S,5S,6R)-4-acetamido-3,5-dihydroxy-6-methyloxan-2-yl [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)oxolan-2-yl]methyl dihydrogen diphosphate (non-preferred name) | 
 | 
|  | | 87Z |  | Name: | [(2~{R},3~{R},4~{S},5~{R},6~{R})-4-acetamido-6-methyl-3,5-bis(oxidanyl)oxan-2-yl] [[(2~{R},3~{S},5~{R})-5-[5-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] hydrogen phosphate |  | Formula: | C18 H29 N3 O15 P2 |  | SMILES: | CC1=CN(C(=O)NC1=O)C1CC(O)C(O1)COP(=O)(O)OP(=O)(O)OC1OC(C)C(O)C(NC(C)=O)C1O |  | InChi: | InChI=1S/C18H29N3O15P2/c1-7-5-21(18(27)20-16(7)26)12-4-10(23)11(34-12)6-32-37(28,29)36-38(30,31)35-17-15(25)13(19-9(3)22)14(24)8(2)33-17/h5,8,10-15,17,23-25H,4,6H2,1-3H3,(H,19,22)(H,28,29)(H,30,31)(H,20,26,27)/t8-,10+,11-,12-,13+,14+,15-,17-/m1/s1 |  | Definition date: | 2021-09-09 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | (2R,3R,4S,5R,6R)-4-acetamido-3,5-dihydroxy-6-methyloxan-2-yl [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)oxolan-2-yl]methyl dihydrogen diphosphate (non-preferred name) | 
 | 
|  | | 89W |  | Name: | N-[(3R)-piperidin-3-yl]benzamide |  | Formula: | C12 H16 N2 O |  | SMILES: | O=C(NC1CCCNC1)c1ccccc1 |  | InChi: | InChI=1S/C12H16N2O/c15-12(10-5-2-1-3-6-10)14-11-7-4-8-13-9-11/h1-3,5-6,11,13H,4,7-9H2,(H,14,15)/t11-/m1/s1 |  | Definition date: | 2021-09-14 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | N-[(3R)-piperidin-3-yl]benzamide | 
 | 
|  | | 8A5 |  | Name: | 4-[(3,4-dimethoxyphenyl)methyl]morpholine |  | Formula: | C13 H19 N O3 |  | SMILES: | COc1ccc(cc1OC)CN1CCOCC1 |  | InChi: | InChI=1S/C13H19NO3/c1-15-12-4-3-11(9-13(12)16-2)10-14-5-7-17-8-6-14/h3-4,9H,5-8,10H2,1-2H3 |  | Definition date: | 2021-09-14 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | 4-[(3,4-dimethoxyphenyl)methyl]morpholine | 
 | 
|  | | 8AB |  | Name: | (3S)-3-methyl-1-(6-methylpyridin-2-yl)piperazine |  | Formula: | C11 H17 N3 |  | SMILES: | Cc1nc(ccc1)N1CC(C)NCC1 |  | InChi: | InChI=1S/C11H17N3/c1-9-4-3-5-11(13-9)14-7-6-12-10(2)8-14/h3-5,10,12H,6-8H2,1-2H3/t10-/m0/s1 |  | Definition date: | 2021-09-14 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | (3S)-3-methyl-1-(6-methylpyridin-2-yl)piperazine | 
 | 
|  | | 8AK |  | Name: | N-cyclopropyl-5-methyl-N-(propan-2-yl)-1,2-oxazole-3-carboxamide |  | Formula: | C11 H16 N2 O2 |  | SMILES: | Cc1cc(no1)C(=O)N(C1CC1)C(C)C |  | InChi: | InChI=1S/C11H16N2O2/c1-7(2)13(9-4-5-9)11(14)10-6-8(3)15-12-10/h6-7,9H,4-5H2,1-3H3 |  | Definition date: | 2021-09-14 |  | Last modified: | 2021-09-17 |  | Release date: | 2021-09-22 |  | Identifier: | N-cyclopropyl-5-methyl-N-(propan-2-yl)-1,2-oxazole-3-carboxamide | 
 |